| 1001 | Phospholipids in large HDL | GCST90497853 | 12.38 |
| 1002 | Concentration of HDL particles | GCST90092826 | 12.36 |
| 1003 | PM20D1 levels | GCST90470268 | 12.36 |
| 1004 | Triglycerides in large VLDL (UKB data field 23501) | GCST90269598 | 12.36 |
| 1005 | Phosphatidylcholine diacyl C38:4 levels | GCST90240046 | 12.35 |
| 1006 | Phospholipids in IDL | GCST90497626 | 12.34 |
| 1007 | EPHA4 levels | GCST90469131 | 12.33 |
| 1008 | Cholelithiasis | digestive | UKBB00000131 | 12.33 |
| 1009 | DTI TBSS L1 Anterior corona radiata R | GCST90384450 | 12.31 |
| 1010 | Free cholesterol in HDL (UKB data field 23422) | GCST90269519 | 12.30 |
| 1011 | C1RL levels | GCST90468492 | 12.30 |
| 1012 | EVI5 levels | GCST90469158 | 12.30 |
| 1013 | Triacylglycerol_56:7_[M+NH4]1+ levels | GCST90060551 | 12.28 |
| 1014 | Red cell distribution width | GCST006804 | 12.28 |
| 1015 | TDRKH levels | GCST90470827 | 12.25 |
| 1016 | CDKN1A/FXN ratio | GCST90313971 | 12.25 |
| 1017 | FEN1 levels | GCST90469213 | 12.23 |
| 1018 | Triglyceride levels in large LDL | GCST90092866 | 12.23 |
| 1019 | FN1 levels | GCST90469255 | 12.20 |
| 1020 | Roast chicken liking | GCST90094821 | 12.20 |
| 1021 | X-21441 levels | GCST90200581 | 12.20 |
| 1022 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500333 | 12.19 |
| 1023 | IDP dMRI TBSS ICVF Posterior limb of internal capsule L | GCST90004346 | 12.19 |
| 1024 | PRDX5 levels | GCST90470318 | 12.18 |
| 1025 | Triglycerides to total lipids in medium HDL percentage (UKB data field 23643) | GCST90269740 | 12.17 |
| 1026 | Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302804 | 12.15 |
| 1027 | Immature fraction of reticulocytes | GCST004628 | 12.15 |
| 1028 | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | GCST90003972 | 12.14 |
| 1029 | ITGB5/SIAE ratio | GCST90315234 | 12.13 |
| 1030 | DAG1/MGLL ratio | GCST90314377 | 12.12 |
| 1031 | Omega-3 fatty acids to total fatty acids percentage | GCST90502088 | 12.11 |
| 1032 | Cholesterol esters in very small VLDL | GCST90500740 | 12.11 |
| 1033 | Degree of unsaturation | GCST90502749 | 12.11 |
| 1034 | IDP T1 FAST ROIs R putamen | GCST90002552 | 12.10 |
| 1035 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497539 | 12.10 |
| 1036 | ITGB5/S100A4 ratio | GCST90315233 | 12.09 |
| 1037 | BA-exvivo rh area MT | GCST90003232 | 12.09 |
| 1038 | Total lipid levels in small HDL | GCST90092950 | 12.08 |
| 1039 | ALOX15B levels | GCST90617547 | 12.04 |
| 1040 | Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers) | FING00000866 | 12.04 |
| 1041 | Monounsaturated fatty acids levels (UKB data field 23447) | GCST90269544 | 12.04 |
| 1042 | Free cholesterol levels in medium HDL | GCST90132679 | 12.04 |
| 1043 | IDP dMRI TBSS ISOVF Corticospinal tract R | GCST90004483 | 12.03 |
| 1044 | Central corneal thickness | GCST006366 | 12.02 |
| 1045 | NUDT5 levels | GCST90470107 | 12.02 |
| 1046 | Triglycerides in VLDL (UKB data field 23408) | GCST90269505 | 12.02 |
| 1047 | Triglycerides to total lipids ratio in small VLDL | GCST90092979 | 12.00 |
| 1048 | Total lipids in IDL | GCST90497601 | 12.00 |
| 1049 | PCDH17/TEK ratio | GCST90315606 | 11.99 |
| 1050 | CASP8/SEPTIN9 ratio | GCST90313658 | 11.98 |
| 1051 | IDP dMRI ProbtrackX ICVF cst l | GCST90004383 | 11.96 |
| 1052 | XG levels | GCST90471082 | 11.94 |
| 1053 | Triglycerides to total lipids ratio in very small VLDL | GCST90093039 | 11.92 |
| 1054 | ICA1/TANK ratio | GCST90315112 | 11.92 |
| 1055 | Cholesterol to total lipids ratio in very small VLDL | GCST90093029 | 11.91 |
| 1056 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502153 | 11.90 |
| 1057 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90500994 | 11.89 |
| 1058 | Alanine levels | GCST003666 | 11.89 |
| 1059 | Methionine sulfone levels | GCST90199961 | 11.89 |
| 1060 | Phospholipids to Total Lipids in IDL percentage | GCST90497644 | 11.84 |
| 1061 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 11.84 |
| 1062 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T413 | ECGU000413 | 11.83 |
| 1063 | BA-exvivo lh thickness BA4p | GCST90003518 | 11.82 |
| 1064 | F9 levels | GCST90469172 | 11.81 |
| 1065 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497576 | 11.81 |
| 1066 | MDK levels | GCST90469877 | 11.81 |
| 1067 | Total triglycerides levels (UKB data field 23407) | GCST90269504 | 11.81 |
| 1068 | ITGB1 levels | GCST90469643 | 11.81 |
| 1069 | NOTCH1 levels | GCST90470065 | 11.80 |
| 1070 | SIRT2/STAT5B ratio | GCST90315846 | 11.80 |
| 1071 | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302715 | 11.79 |
| 1072 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320943 | 11.79 |
| 1073 | Disorders of lipoprotein metabolism and other lipidaemias | FING00000442 | 11.78 |
| 1074 | Total fatty acid levels | GCST90502218 | 11.78 |
| 1075 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 11.78 |
| 1076 | Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616) | GCST90269713 | 11.77 |
| 1077 | CNTNAP2/DPP10 ratio | GCST90314167 | 11.77 |
| 1078 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13 | ECGA000013 | 11.77 |
| 1079 | Total fatty acid levels | GCST90502211 | 11.76 |
| 1080 | SNCG levels | GCST90470695 | 11.74 |
| 1081 | N-acetylmethionine levels | GCST90200289 | 11.74 |
| 1082 | Concentration of very small VLDL particles | GCST90500819 | 11.73 |
| 1083 | Phosphatidylcholine levels | GCST90499248 | 11.73 |
| 1084 | GMPR2 levels | GCST90469367 | 11.71 |
| 1085 | IDP dMRI TBSS L2 Anterior limb of internal capsule R | GCST90004139 | 11.71 |
| 1086 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499431 | 11.69 |
| 1087 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T141 | ECGA000141 | 11.66 |
| 1088 | CA4/TNFSF12 ratio | GCST90313589 | 11.65 |
| 1089 | AmygNuclei rh volume Paralaminar-nucleus | GCST90002666 | 11.65 |
| 1090 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499494 | 11.64 |
| 1091 | HSD17B14 levels | GCST90469483 | 11.64 |
| 1092 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501010 | 11.63 |
| 1093 | Diacylglycerol_44:7_[M+H-H2O]1+ levels | GCST90060240 | 11.62 |
| 1094 | LYPD3 levels | GCST90469828 | 11.60 |
| 1095 | Neuroticism | GCST005232 | 11.59 |
| 1096 | CXCL1 levels | GCST90012019 | 11.59 |
| 1097 | Sphingomyelin_34:1_[M+H]1+ levels | GCST90060239 | 11.56 |
| 1098 | IL4R levels | GCST90469598 | 11.54 |
| 1099 | Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302690 | 11.52 |
| 1100 | FST/FSTL3 ratio | GCST90314882 | 11.51 |
| 1101 | Degree of unsaturation | GCST90500162 | 11.51 |
| 1102 | METAP2 levels | GCST90469894 | 11.51 |
| 1103 | Cholesterol in Medium HDL | GCST90498495 | 11.51 |
| 1104 | LGALS8/SOD2 ratio | GCST90315320 | 11.46 |
| 1105 | EREG/HBEGF ratio | GCST90314702 | 11.43 |
| 1106 | IL18BP/ROR1 ratio | GCST90315155 | 11.42 |
| 1107 | Irritable mood | GCST006941 | 11.39 |
| 1108 | Omega-3 fatty acids to total fatty acids percentage | GCST90502450 | 11.37 |
| 1109 | CD84/SEMA4D ratio | GCST90313917 | 11.33 |
| 1110 | TXNRD1 levels | GCST90470994 | 11.33 |
| 1111 | GALNT10/SEMA7A ratio | GCST90314915 | 11.33 |
| 1112 | CANT1/ROR1 ratio | GCST90313620 | 11.32 |
| 1113 | Own or rent accommodation lived in - Own outright (by you or someone in your household) | Household | UKBB00000623 | 11.30 |
| 1114 | APP/HBEGF ratio | GCST90313324 | 11.28 |
| 1115 | CPM/LAMP2 ratio | GCST90314215 | 11.26 |
| 1116 | ITGA5/LILRA2 ratio | GCST90315204 | 11.24 |
| 1117 | DNAJB1/EIF4B ratio | GCST90314508 | 11.23 |
| 1118 | Triglycerides to phosphoglycerides ratio (UKB data field 23435) | GCST90269532 | 11.22 |
| 1119 | Other diseases of liver | FING00001004 | 11.21 |
| 1120 | Omega-6 fatty acids to total fatty acids percentage | GCST90502544 | 11.21 |
| 1121 | Cholesteryl esters to total lipids ratio in small LDL | GCST90092959 | 11.20 |
| 1122 | Triglycerides in medium HDL | GCST90498672 | 11.20 |
| 1123 | Cholesteryl esters in medium HDL (UKB data field 23569) | GCST90269666 | 11.19 |
| 1124 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9 | ECGA000009 | 11.18 |
| 1125 | KDR/VWF ratio | GCST90315245 | 11.18 |
| 1126 | TYRO3 levels | GCST90470997 | 11.16 |
| 1127 | Cholesteryl esters in small VLDL (UKB data field 23513) | GCST90269610 | 11.15 |
| 1128 | WFDC1 levels | GCST90471074 | 11.14 |
| 1129 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 11.13 |
| 1130 | COL6A3/CST3 ratio | GCST90314174 | 11.13 |
| 1131 | Acylcarnitine (18:2) levels | GCST90024623 | 11.11 |
| 1132 | SCLY/SORD ratio | GCST90315816 | 11.11 |
| 1133 | Takes medication for congestive heart failure? | GCST90475201 | 11.10 |
| 1134 | Free cholesterol to total lipids ratio in large LDL | GCST90092861 | 11.09 |
| 1135 | Congenital malformations of genital organs | FING00000333 | 11.05 |
| 1136 | NCR3LG1 levels | GCST90470010 | 11.04 |
| 1137 | DTI TBSS L3 Sagittal stratum L | GCST90384555 | 11.03 |
| 1138 | SF3B4 levels | GCST90470609 | 11.03 |
| 1139 | Operation code - spinal laminectomy | Operations | UKBB00000564 | 11.02 |
| 1140 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501045 | 11.02 |
| 1141 | IDP dMRI TBSS FA Superior cerebellar peduncle L | GCST90003890 | 11.00 |
| 1142 | Dihomo-linoleoylcarnitine (C20:2) levels | GCST90200144 | 10.99 |
| 1143 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498885 | 10.98 |
| 1144 | IL18R1 levels | GCST90241607 | 10.97 |
| 1145 | aseg lh intensity Lateral-Ventricle | GCST90003764 | 10.97 |
| 1146 | OSCAR/TNFRSF14 ratio | GCST90315588 | 10.96 |
| 1147 | X-14626 levels | GCST90243861 | 10.96 |
| 1148 | BA-exvivo lh thickness BA3b | GCST90003516 | 10.95 |
| 1149 | MPI levels | GCST90469936 | 10.95 |
| 1150 | Triglycerides in large HDL | GCST90497882 | 10.95 |
| 1151 | Ratio of monounsaturated fatty acids to total fatty acids | GCST90092929 | 10.94 |
| 1152 | Hematocrit | GCST90278634 | 10.94 |
| 1153 | Plasma cystathionine levels in chronic kidney disease | GCST90264974 | 10.94 |
| 1154 | Plasma 4-guanidinobutanoate levels in chronic kidney disease | GCST90264620 | 10.92 |
| 1155 | Type 2 diabetes | GCST90086072 | 10.91 |
| 1156 | HippSubfield lh volume Whole-hippocampal-head | GCST90002688 | 10.88 |
| 1157 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 10.88 |
| 1158 | High myopia | GCST009962 | 10.88 |
| 1159 | Saturated fatty acids levels | GCST90502659 | 10.87 |
| 1160 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T108 | ECGA000108 | 10.86 |
| 1161 | BLMH/PEAR1 ratio | GCST90313519 | 10.84 |
| 1162 | CD74/TNFRSF21 ratio | GCST90313897 | 10.84 |
| 1163 | Atherosclerosis, excluding cerebral and coronary sclerosis | FING00000123 | 10.84 |
| 1164 | CDKN1A/TBL1X ratio | GCST90313977 | 10.83 |
| 1165 | SEC31A levels | GCST90470563 | 10.82 |
| 1166 | Triglycerides to Total Lipids in Medium HDL percentage | GCST90498689 | 10.82 |
| 1167 | Father's age | Family history | UKBB00000240 | 10.82 |
| 1168 | DTI TBSS MD Anterior corona radiata L | GCST90384595 | 10.82 |
| 1169 | ACY1/GSTA1 ratio | GCST90313163 | 10.80 |
| 1170 | FST levels | GCST90469273 | 10.79 |
| 1171 | FOLR2/THY1 ratio | GCST90314867 | 10.78 |
| 1172 | HDL cholesterol levels (UKB data field 23406) | GCST90269503 | 10.78 |
| 1173 | GALNT2 levels | GCST90469296 | 10.78 |
| 1174 | Triglycerides in medium HDL (UKB data field 23571) | GCST90269668 | 10.78 |
| 1175 | CLEC1B/VSIR ratio | GCST90314106 | 10.73 |
| 1176 | ENO2 levels | GCST90469110 | 10.72 |
| 1177 | PDGFRA levels | GCST90470191 | 10.70 |
| 1178 | Total triglycerides levels | GCST003664 | 10.69 |
| 1179 | CEACAM8/VNN2 ratio | GCST90314005 | 10.69 |
| 1180 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T404 | ECGU000404 | 10.68 |
| 1181 | Ever worried more than most people would in similar situation | Anxiety | UKBB00000227 | 10.67 |
| 1182 | Degree of unsaturation | GCST90502737 | 10.67 |
| 1183 | aseg rh volume Pallidum | GCST90002640 | 10.66 |
| 1184 | CXCL6 levels | GCST90468933 | 10.66 |
| 1185 | Medication for pain relief, constipation, heartburn - Paracetamol | Medication | UKBB00000459 | 10.66 |
| 1186 | DTI TBSS L3 Posterior corona radiata L | GCST90384551 | 10.65 |
| 1187 | DTI autoptx MD ilf l tract | GCST90385234 | 10.65 |
| 1188 | Triglyceride levels | GCST90239663 | 10.64 |
| 1189 | BA-exvivo rh area BA3b | GCST90003224 | 10.63 |
| 1190 | Cholesterol to total lipids ratio in large LDL | GCST90092857 | 10.63 |
| 1191 | Mean corpuscular hemoglobin variance | GCST90565693 | 10.63 |
| 1192 | Linoleic acid levels | GCST90502010 | 10.62 |
| 1193 | Mean corpuscular haemoglobin concentration | Blood count | UKBB00000448 | 10.60 |
| 1194 | NGRN levels | GCST90470045 | 10.60 |
| 1195 | DTI autoptx L3 ilf l tract | GCST90385207 | 10.60 |
| 1196 | APOB/APOA1 ratio | GCST90497158 | 10.59 |
| 1197 | Polyunsaturated fatty acid levels | GCST90502622 | 10.58 |
| 1198 | Fasting blood glucose | GCST005186 | 10.58 |
| 1199 | DNMBP/TBC1D5 ratio | GCST90314519 | 10.57 |
| 1200 | Diabetes type 2 with peripheral circulatory (PheCode 250.25) | GCST90475678 | 10.57 |
| 1201 | Cholesteryl esters in HDL (UKB data field 23418) | GCST90269515 | 10.56 |
| 1202 | Polyunsaturated fatty acid levels | GCST90502618 | 10.55 |
| 1203 | Triglycerides to Total Lipids in Very Large HDL percentage | GCST90500508 | 10.55 |
| 1204 | CD58 levels | GCST90468638 | 10.53 |
| 1205 | BCAM/ICAM4 ratio | GCST90313472 | 10.53 |
| 1206 | SH2B3/TBL1X ratio | GCST90315841 | 10.52 |
| 1207 | ITGA2 levels | GCST90469634 | 10.50 |
| 1208 | CHRDL2 levels | GCST90468751 | 10.49 |
| 1209 | aseg lh volume Pallidum | GCST90002623 | 10.49 |
| 1210 | Glycoprotein acetyls levels (UKB data field 23480) | GCST90269577 | 10.48 |
| 1211 | aparc-DKTatlas lh volume precentral | GCST90002884 | 10.48 |
| 1212 | HTRA2/SNAP29 ratio | GCST90315098 | 10.45 |
| 1213 | ASGR1/DCBLD2 ratio | GCST90313364 | 10.45 |
| 1214 | Cholesterol levels in medium HDL | GCST90092892 | 10.44 |
| 1215 | Triglyceride levels in very small VLDL | GCST90093038 | 10.43 |
| 1216 | CTRB1/PLA2G1B ratio | GCST90314307 | 10.43 |
| 1217 | CLMP levels | GCST90468783 | 10.43 |
| 1218 | Raynaud's syndrome | GCST90448187 | 10.43 |
| 1219 | IDP dMRI ProbtrackX MD cst r | GCST90004228 | 10.42 |
| 1220 | CLUL1 levels | GCST90468792 | 10.41 |
| 1221 | CD34 levels | GCST90468626 | 10.40 |
| 1222 | LYN levels | GCST90469826 | 10.40 |
| 1223 | PNMA1 levels | GCST90470276 | 10.39 |
| 1224 | IL3RA levels | GCST90469596 | 10.38 |
| 1225 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502372 | 10.37 |
| 1226 | DTI autoptx L2 fmi tract | GCST90385177 | 10.37 |
| 1227 | Phospholipids to total lipids in small LDL percentage (UKB data field 23624) | GCST90269721 | 10.37 |
| 1228 | Chronic obstructive pulmonary disease | GCST90018587 | 10.36 |
| 1229 | IL22 levels | GCST90088066 | 10.36 |
| 1230 | HGF/PLAUR ratio | GCST90315059 | 10.35 |
| 1231 | Microvirga abundance in stool | GCST90032479 | 10.35 |
| 1232 | GALNT10 levels | GCST90469295 | 10.33 |
| 1233 | Red cell distribution width | GCST90002404 | 10.32 |
| 1234 | DTI autoptx MD ilf r tract | GCST90385235 | 10.31 |
| 1235 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320947 | 10.31 |
| 1236 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500992 | 10.31 |
| 1237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23 | ECGA000023 | 10.30 |
| 1238 | ANGPTL2 levels | GCST90468303 | 10.29 |
| 1239 | HGF levels | GCST90469449 | 10.27 |
| 1240 | Saturated fatty acids levels (UKB data field 23448) | GCST90269545 | 10.26 |
| 1241 | ITPA levels | GCST90469654 | 10.25 |
| 1242 | X-12100--hydroxytryptophan levels | GCST90243702 | 10.24 |
| 1243 | Benign neoplasm: Adrenal gland | FING00000164 | 10.22 |
| 1244 | CTRL levels | GCST90468907 | 10.22 |
| 1245 | SERPINB9 levels | GCST90470593 | 10.20 |
| 1246 | SUSD1/THPO ratio | GCST90315899 | 10.19 |
| 1247 | Cholesterol in Medium HDL | GCST90498492 | 10.18 |
| 1248 | Cholesteryl ester levels in medium HDL | GCST90092894 | 10.18 |
| 1249 | Cholesteryl Esters in Medium HDL | GCST90498538 | 10.18 |
| 1250 | Cholesteryl ester_16:0_[M+NH4]1+ levels | GCST90060211 | 10.16 |
| 1251 | aparc-Desikan lh thickness paracentral | GCST90003461 | 10.14 |
| 1252 | C1QTNF1/COL4A1 ratio | GCST90313552 | 10.14 |
| 1253 | Resting heart rate | GCST90278636 | 10.13 |
| 1254 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501015 | 10.13 |
| 1255 | Cholesterol in small HDL (UKB data field 23575) | GCST90269672 | 10.12 |
| 1256 | BSG/PCDH1 ratio | GCST90313535 | 10.12 |
| 1257 | MASP1 levels | GCST90469863 | 10.11 |
| 1258 | HDL cholesterol levels | GCST90092822 | 10.10 |
| 1259 | Phospholipids in small LDL | GCST90499673 | 10.10 |
| 1260 | IDP dMRI TBSS ICVF Splenium of corpus callosum | GCST90004331 | 10.10 |
| 1261 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499543 | 10.09 |
| 1262 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10 | ECGA000010 | 10.08 |
| 1263 | CHMP6 levels | GCST90468747 | 10.07 |
| 1264 | F-whole food liking (derived food-liking factor) | GCST90094868 | 10.07 |
| 1265 | Cholesterol in Small LDL | GCST90499555 | 10.06 |
| 1266 | CFB levels | GCST90468723 | 10.06 |
| 1267 | LRPAP1 levels | GCST90469800 | 10.05 |
| 1268 | Free cholesterol in very small VLDL | GCST90500777 | 10.05 |
| 1269 | Leisure/social activities - None of the above | Social support | UKBB00000399 | 10.05 |
| 1270 | CELA3A/PLA2G1B ratio | GCST90314014 | 10.05 |
| 1271 | METAP2/PFKFB2 ratio | GCST90315431 | 10.04 |
| 1272 | IDP dMRI TBSS L3 Uncinate fasciculus L | GCST90004216 | 10.02 |
| 1273 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86 | ECGU000086 | 10.02 |
| 1274 | Omega-6 fatty acids to total fatty acids percentage | GCST90502541 | 10.02 |
| 1275 | CD226 levels | GCST90468609 | 10.02 |
| 1276 | RSPO1/SFRP1 ratio | GCST90315791 | 10.01 |
| 1277 | DTI autoptx L1 ilf r tract | GCST90385154 | 10.01 |
| 1278 | PDGF-BB levels | GCST90428430 | 10.00 |
| 1279 | Triglyceride levels in IDL | GCST90092841 | 9.99 |
| 1280 | Triglycerides in small HDL | GCST90499516 | 9.94 |
| 1281 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499804 | 9.93 |
| 1282 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499934 | 9.92 |
| 1283 | RBKS levels | GCST90470433 | 9.90 |
| 1284 | Triglycerides in small HDL | GCST90499519 | 9.90 |
| 1285 | PTPN6/YES1 ratio | GCST90315750 | 9.90 |
| 1286 | FOXO3/MAP3K5 ratio | GCST90314880 | 9.88 |
| 1287 | Total esterified cholesterol levels | GCST90500034 | 9.88 |
| 1288 | CRELD2 levels | GCST90468859 | 9.88 |
| 1289 | PTPRM levels | GCST90470384 | 9.87 |
| 1290 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502645 | 9.87 |
| 1291 | IDP dMRI TBSS L1 Cerebral peduncle L | GCST90004090 | 9.86 |
| 1292 | Polyp of the female genital tract | FING00001190 | 9.86 |
| 1293 | Cholesterol in Large LDL | GCST90497919 | 9.85 |
| 1294 | Triglyceride levels in large HDL | GCST90092854 | 9.84 |
| 1295 | Omega-3 fatty acids to total fatty acids percentage | GCST90502082 | 9.84 |
| 1296 | Triglycerides in HDL | GCST90497464 | 9.84 |
| 1297 | Frailty (Factor 2 - Unhealthy Lifestyle) | GCST90624048 | 9.82 |
| 1298 | IGFBP6/PTGDS ratio | GCST90315137 | 9.81 |
| 1299 | Concentration of small HDL particles (UKB data field 23572) | GCST90269669 | 9.81 |
| 1300 | Benign neoplasm of eye (PheCode 224) | GCST90475626 | 9.81 |
| 1301 | Triglyceride levels in large VLDL | GCST90092878 | 9.81 |
| 1302 | Omega-6 fatty acids to total fatty acids percentage | GCST90502129 | 9.81 |
| 1303 | CSF1/IFNGR1 ratio | GCST90314283 | 9.80 |
| 1304 | LTBR/TNFRSF14 ratio | GCST90315340 | 9.80 |
| 1305 | Low density lipoprotein cholesterol levels | GCST90239657 | 9.80 |
| 1306 | HippSubfield rh volume GC-ML-DG-body | GCST90002703 | 9.79 |
| 1307 | Phosphoglycerides levels (UKB data field 23434) | GCST90269531 | 9.77 |
| 1308 | FSTL1 levels | GCST90469271 | 9.76 |
| 1309 | CELA3A/CTRB1 ratio | GCST90314011 | 9.76 |
| 1310 | FAM177A1 levels | GCST90242458 | 9.75 |
| 1311 | FGFBP2 levels | GCST90469231 | 9.75 |
| 1312 | LDLR/MEGF9 ratio | GCST90315310 | 9.72 |
| 1313 | PODXL2/SCG3 ratio | GCST90315700 | 9.72 |
| 1314 | Financial situation satisfaction | Mental health | UKBB00000249 | 9.72 |
| 1315 | Sphingomyelin_40:3_[M+H]1+ levels | GCST90060348 | 9.71 |
| 1316 | MICB or MICA levels | GCST90469905 | 9.71 |
| 1317 | CDCP1/IL18BP ratio | GCST90313937 | 9.70 |
| 1318 | GM3 ganglioside (d18:1/24:0) levels | GCST90024729 | 9.70 |
| 1319 | Phospholipids in very small VLDL (UKB data field 23518) | GCST90269615 | 9.70 |
| 1320 | HS1BP3 levels | GCST90469477 | 9.70 |
| 1321 | 1-(1-enyl-stearoyl)-GPE (p-18:0) levels | GCST90199910 | 9.67 |
| 1322 | CASP8 levels | GCST90468548 | 9.67 |
| 1323 | Omega-3 fatty acids to total fatty acids percentage | GCST90502451 | 9.66 |
| 1324 | CD300LG/CD93 ratio | GCST90313800 | 9.66 |
| 1325 | PLA2G7 levels | GCST90470249 | 9.66 |
| 1326 | Sphingomyelin_34:0_[M+H]1+ levels | GCST90060241 | 9.66 |
| 1327 | CACNA2D3 levels | GCST90243348 | 9.64 |
| 1328 | CD22/FOLR2 ratio | GCST90313758 | 9.62 |
| 1329 | CEACAM8/RNASE3 ratio | GCST90314004 | 9.61 |
| 1330 | Concentration of small HDL particles | GCST90499461 | 9.61 |
| 1331 | CASP10 levels | GCST90468542 | 9.61 |
| 1332 | Free cholesterol to total lipids in IDL percentage (UKB data field 23612) | GCST90269709 | 9.60 |
| 1333 | Sphingomyelin_42:2_[M+H]1+ levels | GCST90060403 | 9.59 |
| 1334 | ESAM/SCARF1 ratio | GCST90314715 | 9.59 |
| 1335 | Phospholipids in very large VLDL | GCST90500647 | 9.59 |
| 1336 | SH3GLB2 levels | GCST90470621 | 9.58 |
| 1337 | IDP dMRI TBSS L3 External capsule R | GCST90004203 | 9.56 |
| 1338 | IGFBP7 levels | GCST90469532 | 9.55 |
| 1339 | Total concentration of lipoprotein particles | GCST90092990 | 9.55 |
| 1340 | BST1 levels | GCST90468474 | 9.55 |
| 1341 | RAB11FIP3 levels | GCST90470404 | 9.53 |
| 1342 | SNCA levels | GCST90470694 | 9.53 |
| 1343 | ICOSLG levels | GCST90469503 | 9.53 |
| 1344 | Phosphoglycerides levels | GCST90092938 | 9.52 |
| 1345 | LY6D/PLA2G10 ratio | GCST90315345 | 9.52 |
| 1346 | 3-hydroxybutyrate levels (UKB data field 23474) | GCST90269571 | 9.52 |
| 1347 | rfMRI connectivity (ICA100 edge 1090) | GCST90005943 | 9.51 |
| 1348 | Sphingomyelin_36:1_[M+H]1+ levels | GCST90060266 | 9.49 |
| 1349 | CLEC1A/CLEC7A ratio | GCST90314083 | 9.49 |
| 1350 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327 | ECGU000327 | 9.49 |
| 1351 | Cholesteryl Esters in Medium HDL | GCST90498532 | 9.49 |
| 1352 | Pregnenetriol disulfate levels | GCST90200238 | 9.48 |
| 1353 | SDC4/SERPINE1 ratio | GCST90315819 | 9.47 |
| 1354 | Triglycerides to total lipids in large HDL percentage (UKB data field 23638) | GCST90269735 | 9.47 |
| 1355 | SELE levels | GCST90470566 | 9.47 |
| 1356 | CD99L2/CPM ratio | GCST90313925 | 9.46 |
| 1357 | Mean corpuscular hemoglobin concentration | GCST90002391 | 9.46 |
| 1358 | Cholesteryl esters in very large VLDL (UKB data field 23492) | GCST90269589 | 9.46 |
| 1359 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24 | ECGA000024 | 9.45 |
| 1360 | TINAGL1 levels | GCST90470873 | 9.44 |
| 1361 | HEXIM1/TRIAP1 ratio | GCST90315054 | 9.44 |
| 1362 | NCAN levels | GCST90470005 | 9.44 |
| 1363 | aparc-a2009s rh area S-oc-middle+Lunatus | GCST90003427 | 9.44 |
| 1364 | HS6ST1/MEGF9 ratio | GCST90315081 | 9.44 |
| 1365 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500798 | 9.43 |
| 1366 | Irritable bowel syndrome | GCST90016564 | 9.43 |
| 1367 | Succinylcarnitine levels | GCST90243874 | 9.43 |
| 1368 | EIF4G1/TBC1D23 ratio | GCST90314639 | 9.43 |
| 1369 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500929 | 9.42 |
| 1370 | Total lipids in very large VLDL | GCST90500607 | 9.42 |
| 1371 | F11R/PLXNA4 ratio | GCST90314724 | 9.42 |
| 1372 | Sphingomyelins levels | GCST90499972 | 9.41 |
| 1373 | Cholesteryl Esters in Medium LDL | GCST90498738 | 9.41 |
| 1374 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T140 | ECGA000140 | 9.41 |
| 1375 | Triglycerides in VLDL | GCST90500295 | 9.39 |
| 1376 | PRUNE2 levels | GCST90470349 | 9.39 |
| 1377 | CST3/IGFBP6 ratio | GCST90314293 | 9.37 |
| 1378 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 9.37 |
| 1379 | KHK levels | GCST90469675 | 9.36 |
| 1380 | Concentration of very large HDL particles (UKB data field 23551) | GCST90269648 | 9.35 |
| 1381 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T134 | ECGA000134 | 9.35 |
| 1382 | Carotid artery plaque burden | GCST90503076 | 9.35 |
| 1383 | LAMA4 levels | GCST90469731 | 9.34 |
| 1384 | Sphingomyelin_38:2_[M+H]1+ levels | GCST90060302 | 9.33 |
| 1385 | Calcium levels | GCST90025990 | 9.33 |
| 1386 | Concentration of IDL particles | GCST90497614 | 9.32 |
| 1387 | Monounsaturated fatty acid levels | GCST90502036 | 9.31 |
| 1388 | FABP5 levels | GCST90469177 | 9.31 |
| 1389 | GSTA1/SULT2A1 ratio | GCST90314996 | 9.31 |
| 1390 | FURIN/INHBC ratio | GCST90314886 | 9.30 |
| 1391 | PLA2G4A/SNAP29 ratio | GCST90315669 | 9.30 |
| 1392 | Illness, injury, bereavement, stress in last 2 years - None of the above | Mental health | UKBB00000339 | 9.30 |
| 1393 | Cholesteryl ester levels in small VLDL | GCST90092970 | 9.30 |
| 1394 | Saturated fatty acids levels | GCST90502674 | 9.30 |
| 1395 | LAP3 levels | GCST90469737 | 9.28 |
| 1396 | IDP dMRI TBSS L1 Posterior limb of internal capsule L | GCST90004094 | 9.28 |
| 1397 | Total fatty acid levels | GCST90502726 | 9.28 |
| 1398 | FIS1/HSPA1A ratio | GCST90314825 | 9.26 |
| 1399 | Waking up during the night and not easily going back to sleep | GCST90476386 | 9.25 |
| 1400 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107 | ECGU000107 | 9.24 |
| 1401 | Phospholipids in very large VLDL (UKB data field 23490) | GCST90269587 | 9.24 |
| 1402 | ERBIN levels | GCST90469142 | 9.23 |
| 1403 | Cholesterol in very large VLDL (UKB data field 23491) | GCST90269588 | 9.22 |
| 1404 | Left hippocampal volume | GCST90267952 | 9.22 |
| 1405 | Saturated fatty acids levels | GCST90502670 | 9.20 |
| 1406 | wg rh intensity-contrast temporalpole | GCST90003859 | 9.20 |
| 1407 | Ascending aorta diameter | GCST90267390 | 9.20 |
| 1408 | Concentration of large VLDL particles (UKB data field 23495) | GCST90269592 | 9.19 |
| 1409 | SIRT2 levels | GCST90470642 | 9.19 |
| 1410 | Obstructive chronic bronchitis (PheCode 496.21) | GCST90476030 | 9.18 |
| 1411 | Feeling worry | GCST006950 | 9.16 |
| 1412 | Total lipids in large VLDL | GCST90498207 | 9.16 |
| 1413 | CANT1/VSIR ratio | GCST90313621 | 9.16 |
| 1414 | Omega-6 fatty acid levels | GCST90502101 | 9.16 |
| 1415 | PALM levels | GCST90470154 | 9.16 |
| 1416 | DTI TBSS L3 Cingulum hippocampus R | GCST90384560 | 9.15 |
| 1417 | CELA3A levels | GCST90468702 | 9.13 |
| 1418 | CKAP4/PGF ratio | GCST90314075 | 9.13 |
| 1419 | CRTAM/PDCD1 ratio | GCST90314279 | 9.12 |
| 1420 | Cholesteryl Esters in Small LDL | GCST90499586 | 9.12 |
| 1421 | MSRA/P4HB ratio | GCST90315495 | 9.12 |
| 1422 | CDCP1 levels | GCST90468667 | 9.11 |
| 1423 | AmygNuclei lh volume Lateral-nucleus | GCST90002648 | 9.11 |
| 1424 | STAT5B levels | GCST90470759 | 9.11 |
| 1425 | Triglyceride levels in small VLDL | GCST90132667 | 9.11 |
| 1426 | FXYD5 levels | GCST90469283 | 9.10 |
| 1427 | IL17A levels | GCST90469558 | 9.09 |
| 1428 | Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093043 | 9.09 |
| 1429 | GM3 ganglioside (d18:1/24:0) levels | GCST90025340 | 9.08 |
| 1430 | CLIP2/LAT2 ratio | GCST90314128 | 9.08 |
| 1431 | Carnitine levels | GCST90243481 | 9.07 |
| 1432 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320684 | 9.06 |
| 1433 | CALB1 levels | GCST90468526 | 9.06 |
| 1434 | CD46/SELP ratio | GCST90313834 | 9.05 |
| 1435 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T136 | ECGA000136 | 9.03 |
| 1436 | EFEMP1/TGFBR3 ratio | GCST90314597 | 9.02 |
| 1437 | Free cholesterol in very large VLDL (UKB data field 23493) | GCST90269590 | 9.01 |
| 1438 | Principal component-derived dietary pattern 31 | GCST90133036 | 9.01 |
| 1439 | CNPY4 levels | GCST90468800 | 9.00 |
| 1440 | CRELD2/NUCB2 ratio | GCST90314256 | 8.99 |
| 1441 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025115 | 8.98 |
| 1442 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174 | ECGA000174 | 8.98 |
| 1443 | Phospholipids to total lipids ratio in very large VLDL | GCST90093025 | 8.97 |
| 1444 | BSG/CKAP4 ratio | GCST90313531 | 8.97 |
| 1445 | Free cholesterol in small LDL | GCST90499620 | 8.96 |
| 1446 | MET levels | GCST90469895 | 8.95 |
| 1447 | Phospholipids in small LDL | GCST90499681 | 8.94 |
| 1448 | TNFAIP8 levels | GCST90470898 | 8.94 |
| 1449 | FADD/GRAP2 ratio | GCST90314766 | 8.93 |
| 1450 | CELA2A levels | GCST90468701 | 8.91 |
| 1451 | IDP dMRI TBSS MD Sagittal stratum L | GCST90004058 | 8.91 |
| 1452 | rfMRI connectivity (ICA100 edge 495) | GCST90005348 | 8.91 |
| 1453 | Triacylglycerol_46:4_[M+NH4]1+ levels | GCST90060362 | 8.91 |
| 1454 | IL18BP/THBD ratio | GCST90315156 | 8.91 |
| 1455 | GGCT levels | GCST90469334 | 8.89 |
| 1456 | Cereal type - Other (e.g. Cornflakes, Frosties) | Diet | UKBB00000125 | 8.88 |
| 1457 | LRTM2 levels | GCST90469808 | 8.88 |
| 1458 | IDP dMRI TBSS ICVF External capsule R | GCST90004359 | 8.87 |
| 1459 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54 | ECGA000054 | 8.87 |
| 1460 | Phospholipids to total lipids in medium HDL percentage (UKB data field 23639) | GCST90269736 | 8.87 |
| 1461 | CD58/ERBB3 ratio | GCST90313848 | 8.87 |
| 1462 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502049 | 8.87 |
| 1463 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90093046 | 8.87 |
| 1464 | Cholesterol to total lipids in medium LDL percentage (UKB data field 23620) | GCST90269717 | 8.85 |
| 1465 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25 | ECGA000025 | 8.85 |
| 1466 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499288 | 8.85 |
| 1467 | CCL14/CST3 ratio | GCST90313679 | 8.85 |
| 1468 | DKK1/SDC4 ratio | GCST90314479 | 8.84 |
| 1469 | Triacylglycerol_52:3_[M+NH4]1+ levels | GCST90060509 | 8.84 |
| 1470 | Triglyceride levels in small LDL | GCST90092966 | 8.83 |
| 1471 | GRAP2/LACTB2 ratio | GCST90314980 | 8.83 |
| 1472 | CDH5/PEAR1 ratio | GCST90313959 | 8.83 |
| 1473 | Immature fraction of reticulocytes | GCST90002387 | 8.83 |
| 1474 | Concentration of very large VLDL particles | GCST90500628 | 8.83 |
| 1475 | Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney disease | GCST90264207 | 8.82 |
| 1476 | ENG/NCAM2 ratio | GCST90314647 | 8.82 |
| 1477 | Free cholesterol in large LDL | GCST90497987 | 8.82 |
| 1478 | Cholesterol in small VLDL (UKB data field 23512) | GCST90269609 | 8.82 |
| 1479 | FGF19/SCG2 ratio | GCST90314809 | 8.82 |
| 1480 | Lung volume | GCST90016668 | 8.81 |
| 1481 | IDP dMRI TBSS L2 Superior cerebellar peduncle R | GCST90004135 | 8.81 |
| 1482 | CST3/TFF3 ratio | GCST90314299 | 8.80 |
| 1483 | CD58/MCAM ratio | GCST90313852 | 8.80 |
| 1484 | Omega-3 fatty acids to total fatty acids percentage | GCST90502462 | 8.79 |
| 1485 | ATXN10/SLC27A4 ratio | GCST90313399 | 8.78 |
| 1486 | ANGPT1/DKK1 ratio | GCST90313263 | 8.77 |
| 1487 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500975 | 8.77 |
| 1488 | Fasting insulin | GCST90002238 | 8.76 |
| 1489 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 8.75 |
| 1490 | Operative procedures - Total cholecystectomy NEC | Summary Operations | UKBB00000589 | 8.75 |
| 1491 | DTI autoptx L1 ptr r tract | GCST90385159 | 8.75 |
| 1492 | Triglycerides in LDL | GCST90498469 | 8.74 |
| 1493 | OXCT1 levels | GCST90470138 | 8.74 |
| 1494 | VLDL cholesterol levels | GCST90500189 | 8.74 |
| 1495 | Conditional arithmetic | Fluid intelligence / reasoning | UKBB00000145 | 8.72 |
| 1496 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499726 | 8.72 |
| 1497 | Cheese consumption | GCST90133000 | 8.72 |
| 1498 | Cholesteryl esters to total lipids ratio in large LDL | GCST90092859 | 8.72 |
| 1499 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14 | ECGA000014 | 8.72 |
| 1500 | SEMA4D levels | GCST90470573 | 8.72 |
| 1501 | ESAM levels | GCST90469152 | 8.71 |
| 1502 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501050 | 8.71 |
| 1503 | Triacylglycerol_52:6_[M+NH4]1+ levels | GCST90060504 | 8.70 |
| 1504 | PILRA/TNFRSF1A ratio | GCST90315655 | 8.69 |
| 1505 | WASHC3 levels | GCST90471069 | 8.68 |
| 1506 | FURIN/IGSF3 ratio | GCST90314885 | 8.68 |
| 1507 | BACH1/DIABLO ratio | GCST90313437 | 8.67 |
| 1508 | Haemorrhoidal disease | GCST90014033 | 8.67 |
| 1509 | Lung cancer | GCST90011812 | 8.66 |
| 1510 | Cholesteryl esters in very large HDL (UKB data field 23555) | GCST90269652 | 8.66 |
| 1511 | Cholesterol, total | GCST002221 | 8.65 |
| 1512 | Total lipids in very small VLDL (UKB data field 23517) | GCST90269614 | 8.65 |
| 1513 | Mean corpuscular haemoglobin concentration (UKB data field 30060) | GCST90468085 | 8.65 |
| 1514 | HMCN2 levels | GCST90469461 | 8.65 |
| 1515 | HYOU1/ROR1 ratio | GCST90315104 | 8.64 |
| 1516 | CSF1/SEMA3F ratio | GCST90314288 | 8.63 |
| 1517 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501068 | 8.63 |
| 1518 | TNFSF12/TNFSF13 ratio | GCST90315941 | 8.62 |
| 1519 | APOC1 levels | GCST90468336 | 8.62 |
| 1520 | CD59/SCARB2 ratio | GCST90313859 | 8.60 |
| 1521 | Alcohol intake versus 10 years previously | Alcohol | UKBB00000024 | 8.60 |
| 1522 | IDP dMRI TBSS MD Corticospinal tract R | GCST90004033 | 8.60 |
| 1523 | CLSTN2/MATN2 ratio | GCST90314143 | 8.59 |
| 1524 | Monounsaturated fatty acid levels | GCST90502358 | 8.59 |
| 1525 | FCN1 levels | GCST90618565 | 8.59 |
| 1526 | Shoulder lesions | FING00001303 | 8.59 |
| 1527 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108 | ECGU000108 | 8.58 |
| 1528 | ALB levels | GCST90475106 | 8.58 |
| 1529 | METAP2/PLPBP ratio | GCST90315432 | 8.58 |
| 1530 | AMBP/ASGR1 ratio | GCST90313251 | 8.57 |
| 1531 | Cholesterol in very large HDL (UKB data field 23554) | GCST90269651 | 8.57 |
| 1532 | Sphingomyelin_41:2_[M+H]1+ levels | GCST90060383 | 8.57 |
| 1533 | CDKN1A/TXLNA ratio | GCST90313979 | 8.57 |
| 1534 | Concentration of very large VLDL particles (UKB data field 23488) | GCST90269585 | 8.57 |
| 1535 | APP/CD40LG ratio | GCST90313319 | 8.55 |
| 1536 | CD33 levels | GCST90468625 | 8.55 |
| 1537 | Sphingomyelin (d18:1/16:0) levels | GCST90025744 | 8.55 |
| 1538 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus L | GCST90004368 | 8.54 |
| 1539 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 8.54 |
| 1540 | MERTK levels | GCST90469890 | 8.53 |
| 1541 | BACH1/CNST ratio | GCST90313436 | 8.52 |
| 1542 | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | GCST90200103 | 8.52 |
| 1543 | APRT/EREG ratio | GCST90313335 | 8.52 |
| 1544 | ENO1 levels | GCST90469109 | 8.52 |
| 1545 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500983 | 8.51 |
| 1546 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253 | ECGU000253 | 8.50 |
| 1547 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 8.50 |
| 1548 | Pure hypercholesterolaemia | FING00001230 | 8.49 |
| 1549 | CD99/RELT ratio | GCST90313930 | 8.49 |
| 1550 | Total lipids in small HDL | GCST90499443 | 8.49 |
| 1551 | CD93 levels | GCST90468656 | 8.49 |
| 1552 | Triglycerides | GCST000758 | 8.49 |
| 1553 | CA1/TGM2 ratio | GCST90313575 | 8.48 |
| 1554 | ESAM/JAM2 ratio | GCST90314712 | 8.48 |
| 1555 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T414 | ECGU000414 | 8.47 |
| 1556 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T90 | ECGU000090 | 8.47 |
| 1557 | Phlebitis and thrombophlebitis (not including DVT) | FING00001165 | 8.47 |
| 1558 | ACVRL1 levels | GCST90468211 | 8.47 |
| 1559 | Cholesteryl ester levels in HDL | GCST90092823 | 8.45 |
| 1560 | ERBB3 levels | GCST90469140 | 8.45 |
| 1561 | aseg global intensity 4th-Ventricle | GCST90003752 | 8.43 |
| 1562 | Concentration of very small VLDL particles (UKB data field 23516) | GCST90269613 | 8.43 |
| 1563 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 8.41 |
| 1564 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255 | ECGA000255 | 8.41 |
| 1565 | Cholesterol to total lipids ratio in medium LDL | GCST90092905 | 8.41 |
| 1566 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90093042 | 8.40 |
| 1567 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499637 | 8.40 |
| 1568 | KITLG/PLTP ratio | GCST90315252 | 8.40 |
| 1569 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377 | ECGA000377 | 8.38 |
| 1570 | CEACAM19 levels | GCST90468691 | 8.38 |
| 1571 | Concentration of small LDL particles (UKB data field 23544) | GCST90269641 | 8.38 |
| 1572 | Familial combined hyperlipidemia defined by Mexico criteria | GCST90104007 | 8.37 |
| 1573 | CEP112 levels | GCST90468708 | 8.37 |
| 1574 | Phospholipids in large VLDL (UKB data field 23497) | GCST90269594 | 8.37 |
| 1575 | ALB levels | GCST90475103 | 8.36 |
| 1576 | Spread type: Butter and margarine vs never use spread (UKB data field 1428) | GCST90132948 | 8.34 |
| 1577 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475454 | 8.34 |
| 1578 | LDL cholesterol | GCST000759 | 8.32 |
| 1579 | CRADD/FADD ratio | GCST90314237 | 8.32 |
| 1580 | Asthma mixed form (mode) (more control exclusions) | FING00000116 | 8.32 |
| 1581 | IDP dMRI TBSS FA Cerebral peduncle R | GCST90003891 | 8.31 |
| 1582 | SCARA5/TGFBI ratio | GCST90315809 | 8.31 |
| 1583 | PRND levels | GCST90470333 | 8.30 |
| 1584 | SLITRK6 levels | GCST90470671 | 8.30 |
| 1585 | METAP2/USP8 ratio | GCST90315434 | 8.30 |
| 1586 | Saturated fatty acids levels | GCST90502185 | 8.30 |
| 1587 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498881 | 8.30 |
| 1588 | ADH4/SORD ratio | GCST90313196 | 8.30 |
| 1589 | Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10) | GCST90042678 | 8.29 |
| 1590 | ICD10 E28.2: Polycystic ovarian syndrome | GCST90454205 | 8.29 |
| 1591 | ADGRE2/CD58 ratio | GCST90313175 | 8.28 |
| 1592 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109 | ECGU000109 | 8.28 |
| 1593 | FIS1 levels | GCST90469240 | 8.26 |
| 1594 | rfMRI amplitudes (ICA25 node 14) | GCST90004581 | 8.26 |
| 1595 | CDKN1A/PLA2G4A ratio | GCST90313974 | 8.26 |
| 1596 | Autoimmune hepatitis | GCST90018565 | 8.26 |
| 1597 | DCBLD2/PLA2G15 ratio | GCST90314428 | 8.25 |
| 1598 | CLK2 levels | GCST90240975 | 8.25 |
| 1599 | Phospholipids in small HDL (UKB data field 23574) | GCST90269671 | 8.25 |
| 1600 | Cholesterol to Total Lipids in Small VLDL percentage | GCST90499760 | 8.25 |
| 1601 | Total cholines levels (UKB data field 23436) | GCST90269533 | 8.23 |
| 1602 | IDP dMRI TBSS MD Cingulum hippocampus R | GCST90004063 | 8.23 |
| 1603 | NIT2 levels | GCST90470051 | 8.23 |
| 1604 | Sphingomyelin_34:2_[M+H]1+ levels | GCST90060235 | 8.22 |
| 1605 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499287 | 8.21 |
| 1606 | Phosphatidylcholine diacyl C36:4 levels | GCST90240040 | 8.21 |
| 1607 | DCTN1/TRIAP1 ratio | GCST90314434 | 8.21 |
| 1608 | KAZALD1 levels | GCST90469665 | 8.20 |
| 1609 | Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary Administration | UKBB00000420 | 8.20 |
| 1610 | PLA2G4A/PPP1R12A ratio | GCST90315666 | 8.20 |
| 1611 | Hypertrophy of breast in women and men | FING00000645 | 8.20 |
| 1612 | Left ventricular end diastole anterospetal wall thickness | GCST90278519 | 8.20 |
| 1613 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95 | ECGU000095 | 8.19 |
| 1614 | PMVK levels | GCST90470272 | 8.17 |
| 1615 | QC rfMRI cleaned inverse tSNR | GCST90006358 | 8.15 |
| 1616 | Concentration of small VLDL particles | GCST90499868 | 8.15 |
| 1617 | GALNT3 levels | GCST90469297 | 8.15 |
| 1618 | rfMRI amplitudes (ICA100 node 2) | GCST90004590 | 8.14 |
| 1619 | ARHGEF12/IRAK4 ratio | GCST90313350 | 8.14 |
| 1620 | Total cholesterol levels in medium VLDL | GCST90132689 | 8.14 |
| 1621 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500956 | 8.14 |
| 1622 | AMOTL2 levels | GCST90468294 | 8.13 |
| 1623 | LRP11/NECTIN2 ratio | GCST90315329 | 8.13 |
| 1624 | IDP dMRI TBSS L1 Corticospinal tract R | GCST90004081 | 8.13 |
| 1625 | LPCAT2 levels | GCST90241841 | 8.13 |
| 1626 | Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels | GCST90060280 | 8.13 |
| 1627 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 8.13 |
| 1628 | Phosphatidylcholine (40:8) levels | GCST90024299 | 8.12 |
| 1629 | CLPS/CTRB1 ratio | GCST90314139 | 8.12 |
| 1630 | Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626) | GCST90269723 | 8.11 |
| 1631 | Cholesteryl ester (16:2) levels | GCST90025238 | 8.10 |
| 1632 | SPOCK2 levels | GCST90242987 | 8.10 |
| 1633 | Total lipids in large VLDL (UKB data field 23496) | GCST90269593 | 8.09 |
| 1634 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 8.09 |
| 1635 | DTI TBSS MD Cingulum hippocampus R | GCST90384608 | 8.08 |
| 1636 | Free cholesterol in large VLDL (UKB data field 23500) | GCST90269597 | 8.08 |
| 1637 | BA-exvivo rh area BA3a | GCST90003223 | 8.08 |
| 1638 | Benign neoplasm of eye, uveal (PheCode 224.1) | GCST90475629 | 8.07 |
| 1639 | Hemoglobin concentration variance | GCST90565685 | 8.06 |
| 1640 | Phosphatidylcholine (14:0_22:6) levels | GCST90024234 | 8.06 |
| 1641 | Triglyceride levels in very large HDL | GCST90132636 | 8.05 |
| 1642 | Triglyceride levels in medium HDL | GCST90092902 | 8.05 |
| 1643 | DTI autoptx MD ptr l tract | GCST90385239 | 8.04 |
| 1644 | APOH levels | GCST90468340 | 8.04 |
| 1645 | ENO2/PRSS27 ratio | GCST90314666 | 8.03 |
| 1646 | IDP dMRI TBSS L3 Superior cerebellar peduncle R | GCST90004183 | 8.03 |
| 1647 | FLT1/VEGFA ratio | GCST90314858 | 8.02 |
| 1648 | Phospholipids to Total Lipids in Small VLDL percentage | GCST90499895 | 8.02 |
| 1649 | Familial combined hyperlipidemia defined by Brunzell criteria | GCST90104003 | 8.02 |
| 1650 | High density lipoprotein cholesterol levels | GCST90239651 | 8.02 |
| 1651 | CASP1 levels | GCST90468543 | 8.02 |
| 1652 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90093048 | 8.02 |
| 1653 | Total testosterone levels | GCST90012114 | 8.02 |
| 1654 | LUZP2 levels | GCST90469819 | 8.01 |
| 1655 | GFRAL levels | GCST90469331 | 8.01 |
| 1656 | CASP3/LYN ratio | GCST90313635 | 8.01 |
| 1657 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499073 | 8.00 |
| 1658 | Phospholipids in small VLDL (UKB data field 23511) | GCST90269608 | 7.99 |
| 1659 | Triglyceride levels in small HDL | GCST90092954 | 7.97 |
| 1660 | Concentration of VLDL particles | GCST90500250 | 7.97 |
| 1661 | Total cholesterol levels | GCST90500022 | 7.95 |
| 1662 | Omega-3 fatty acids to total fatty acids percentage | GCST90502463 | 7.94 |
| 1663 | Main speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000416 | 7.93 |
| 1664 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376 | ECGA000376 | 7.92 |
| 1665 | Saturated fatty acids levels | GCST90502671 | 7.92 |
| 1666 | TEK levels | GCST90470829 | 7.90 |
| 1667 | TNFRSF11A levels | GCST90470902 | 7.90 |
| 1668 | ADGRG2/ITGB1 ratio | GCST90313185 | 7.90 |
| 1669 | Diabetic retinopathy (PheCode 250.7) | GCST90475689 | 7.89 |
| 1670 | LBR/POLR2F ratio | GCST90315297 | 7.89 |
| 1671 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 7.89 |
| 1672 | L1CAM levels | GCST90469723 | 7.87 |
| 1673 | APOA4 levels | GCST90468333 | 7.87 |
| 1674 | low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed) | GCST90475420 | 7.87 |
| 1675 | BCAM/EPO ratio | GCST90313471 | 7.85 |
| 1676 | Concentration of chylomicrons and extremely large VLDL particles | GCST90093047 | 7.85 |
| 1677 | CD69/SNAP23 ratio | GCST90313886 | 7.85 |
| 1678 | IL27 levels | GCST90012017 | 7.85 |
| 1679 | TRIAP1 levels | GCST90470963 | 7.84 |
| 1680 | DNAJB1/SIRT2 ratio | GCST90314511 | 7.84 |
| 1681 | Salad leaves liking | GCST90094823 | 7.82 |
| 1682 | NUB1 levels | GCST90470099 | 7.82 |
| 1683 | IL6R levels | GCST90469602 | 7.81 |
| 1684 | FLRT2 levels | GCST90469248 | 7.81 |
| 1685 | Triglycerides in very large HDL | GCST90500481 | 7.81 |
| 1686 | Allergic rhinitis | GCST90086042 | 7.81 |
| 1687 | DCN levels | GCST90468956 | 7.80 |
| 1688 | BLVRB/HMBS ratio | GCST90313526 | 7.78 |
| 1689 | FLT4/ICAM2 ratio | GCST90314860 | 7.78 |
| 1690 | BIN1 levels | GCST90090757 | 7.78 |
| 1691 | AmygNuclei lh volume Whole-amygdala | GCST90002657 | 7.78 |
| 1692 | CHGB levels | GCST90468742 | 7.77 |
| 1693 | Ankylosing spondylitis, strict definition | FING00000090 | 7.77 |
| 1694 | TMEM106A levels | GCST90470886 | 7.77 |
| 1695 | Lysoalkylphosphatidylcholine (O-24:2) levels | GCST90025438 | 7.76 |
| 1696 | Triglyceride levels in very large HDL | GCST90093014 | 7.76 |
| 1697 | CABP2 levels | GCST90468519 | 7.75 |
| 1698 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90093040 | 7.75 |
| 1699 | LHPP levels | GCST90469768 | 7.75 |
| 1700 | PCSK9 levels | GCST90470177 | 7.74 |
| 1701 | ThalamNuclei rh volume CeM | GCST90002751 | 7.74 |
| 1702 | FLT1/TFPI2 ratio | GCST90314856 | 7.72 |
| 1703 | AGRP levels | GCST90468256 | 7.72 |
| 1704 | Cirrhosis | GCST90319877 | 7.72 |
| 1705 | SLC35G2 levels | GCST90242857 | 7.72 |
| 1706 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256 | ECGA000256 | 7.71 |
| 1707 | IDP dMRI TBSS MO Fornix | GCST90003957 | 7.71 |
| 1708 | SDC4/SELP ratio | GCST90315817 | 7.70 |
| 1709 | IDP dMRI TBSS ICVF Body of corpus callosum | GCST90004330 | 7.69 |
| 1710 | Cholesteryl ester_18:2_[M+NH4]1+ levels | GCST90060220 | 7.69 |
| 1711 | Osteoporosis, osteopenia and pathological fracture (PheCode 743) | GCST90476258 | 7.69 |
| 1712 | B3GNT7 levels | GCST90468411 | 7.68 |
| 1713 | aparc-Desikan rh area fusiform | GCST90003113 | 7.67 |
| 1714 | Total testosterone levels | GCST90012112 | 7.66 |
| 1715 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500958 | 7.66 |
| 1716 | Sphingomyelin_38:1_[M+H]1+ levels | GCST90060306 | 7.66 |
| 1717 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 7.66 |
| 1718 | COMP/TGFBI ratio | GCST90314192 | 7.65 |
| 1719 | FKBP4/FKBP5 ratio | GCST90314838 | 7.65 |
| 1720 | C3 levels | GCST90468498 | 7.64 |
| 1721 | Total lipids in small VLDL (UKB data field 23510) | GCST90269607 | 7.64 |
| 1722 | Total fatty acid levels | GCST90502722 | 7.64 |
| 1723 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175 | ECGA000175 | 7.64 |
| 1724 | CD99/KITLG ratio | GCST90313924 | 7.64 |
| 1725 | Cholesteryl esters in medium LDL (UKB data field 23541) | GCST90269638 | 7.63 |
| 1726 | AmygNuclei rh volume Basal-nucleus | GCST90002659 | 7.62 |
| 1727 | F12 levels | GCST90469166 | 7.62 |
| 1728 | Insomnia (weighted GWA) | GCST90267287 | 7.61 |
| 1729 | Cholesteryl ester levels in very large VLDL | GCST90093018 | 7.61 |
| 1730 | Triglyceride levels in small VLDL | GCST90092978 | 7.61 |
| 1731 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498258 | 7.60 |
| 1732 | Cholesterol to total lipids in medium HDL percentage (UKB data field 23640) | GCST90269737 | 7.59 |
| 1733 | Triglycerides in LDL | GCST90498472 | 7.59 |
| 1734 | Sphingomyelin_42:3_[M+H]1+ levels | GCST90060399 | 7.59 |
| 1735 | IDP dMRI TBSS FA Posterior limb of internal capsule R | GCST90003895 | 7.59 |
| 1736 | Total triglycerides levels | GCST90500140 | 7.58 |
| 1737 | APOB/APOA1 ratio | GCST90092810 | 7.58 |
| 1738 | Triglycerides x low social support interaction (2df test) | GCST90570681 | 7.57 |
| 1739 | LBR/PSRC1 ratio | GCST90315300 | 7.57 |
| 1740 | EGFR levels | GCST90469085 | 7.57 |
| 1741 | COL6A3/HSPG2 ratio | GCST90314175 | 7.57 |
| 1742 | Triglycerides to total lipids in very large HDL percentage (UKB data field 23633) | GCST90269730 | 7.57 |
| 1743 | INPP1 levels | GCST90469616 | 7.56 |
| 1744 | DCBLD2 levels | GCST90468952 | 7.56 |
| 1745 | Total lipids in small LDL (UKB data field 23545) | GCST90269642 | 7.55 |
| 1746 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 7.55 |
| 1747 | CASP10/PRTFDC1 ratio | GCST90313627 | 7.53 |
| 1748 | Triacylglycerol_50:5_[M+NH4]1+ levels | GCST90060463 | 7.53 |
| 1749 | Free cholesterol to total lipids in large HDL percentage (UKB data field 23637) | GCST90269734 | 7.53 |
| 1750 | Cholesterol levels in small VLDL | GCST90092968 | 7.52 |
| 1751 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498784 | 7.52 |
| 1752 | AMY2B levels | GCST90468299 | 7.51 |
| 1753 | LGALS8 levels | GCST90469764 | 7.51 |
| 1754 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T403 | ECGU000403 | 7.50 |
| 1755 | Treatment/medication code - paracetamol | Medications | UKBB00000853 | 7.50 |
| 1756 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 7.50 |
| 1757 | aparc-a2009s lh area S-temporal-sup | GCST90003369 | 7.50 |
| 1758 | Free cholesterol in very large HDL (UKB data field 23556) | GCST90269653 | 7.50 |
| 1759 | ADGRE5/NOTCH1 ratio | GCST90313181 | 7.50 |
| 1760 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378 | ECGA000378 | 7.49 |
| 1761 | Triglyceride to HDL cholesterol ratio | GCST90295950 | 7.49 |
| 1762 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106 | ECGU000106 | 7.48 |
| 1763 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502567 | 7.48 |
| 1764 | CALCOCO1/IRAG2 ratio | GCST90313604 | 7.48 |
| 1765 | Concentration of large VLDL particles | GCST90498226 | 7.48 |
| 1766 | NPTXR levels | GCST90470080 | 7.47 |
| 1767 | Citrate levels | GCST90497200 | 7.47 |
| 1768 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T405 | ECGU000405 | 7.47 |
| 1769 | IDP dMRI TBSS L2 Fornix | GCST90004128 | 7.47 |
| 1770 | Red wine consumption (glasses per month) (UKB data field 1578, 4419) | GCST90132987 | 7.46 |
| 1771 | Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARB | UKBB00000662 | 7.46 |
| 1772 | CDHR5 levels | GCST90468680 | 7.46 |
| 1773 | Burger liking | GCST90094715 | 7.46 |
| 1774 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 7.44 |
| 1775 | ADAM15 levels | GCST90468217 | 7.44 |
| 1776 | IDP dMRI TBSS ICVF Superior cerebellar peduncle L | GCST90004340 | 7.44 |
| 1777 | ECM1 levels | GCST90469065 | 7.44 |
| 1778 | Triglyceride levels in HDL | GCST90092829 | 7.44 |
| 1779 | Triglycerides x depression interaction (2df test) | GCST90570679 | 7.44 |
| 1780 | CPA1/CPB1 ratio | GCST90314202 | 7.44 |
| 1781 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T107 | ECGA000107 | 7.43 |
| 1782 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500920 | 7.43 |
| 1783 | End-diastolic bi-ventricular shape (principal component 2) | GCST90448481 | 7.42 |
| 1784 | ANXA4/HSPB1 ratio | GCST90313292 | 7.42 |
| 1785 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379 | ECGA000379 | 7.41 |
| 1786 | Nervous feelings | Mental health | UKBB00000495 | 7.41 |
| 1787 | LEP levels | GCST003368 | 7.40 |
| 1788 | Red cell distribution width | GCST004621 | 7.40 |
| 1789 | Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264328 | 7.40 |
| 1790 | MZT1 levels | GCST90469988 | 7.40 |
| 1791 | aparc-a2009s lh thickness G-postcentral | GCST90003630 | 7.40 |
| 1792 | Ribothymidine levels in chronic kidney disease | GCST90257554 | 7.40 |
| 1793 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500655 | 7.39 |
| 1794 | PPT1 levels | GCST90427718 | 7.39 |
| 1795 | rfMRI connectivity (ICA100 edge 912) | GCST90005765 | 7.37 |
| 1796 | GLOD4/MIF ratio | GCST90314939 | 7.37 |
| 1797 | ITM2A levels | GCST90469653 | 7.37 |
| 1798 | Cholesteryl ester (16:2) levels | GCST90024628 | 7.36 |
| 1799 | Triglycerides to total lipids ratio in large HDL | GCST90092855 | 7.36 |
| 1800 | Total cholines levels | GCST90092812 | 7.36 |
| 1801 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502043 | 7.35 |
| 1802 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T340 | ECGA000340 | 7.35 |
| 1803 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 7.35 |
| 1804 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498944 | 7.33 |
| 1805 | 1,5-anhydroglucitol (1,5-ag) levels | GCST90243529 | 7.33 |
| 1806 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499740 | 7.33 |
| 1807 | EREG levels | GCST90469145 | 7.32 |
| 1808 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500598 | 7.32 |
| 1809 | CIAPIN1 levels | GCST90468753 | 7.32 |
| 1810 | aparc-a2009s rh area Pole-occipital | GCST90003412 | 7.31 |
| 1811 | COL9A1 levels | GCST90468822 | 7.31 |
| 1812 | Spread type - Never/rarely use spread | Diet | UKBB00000794 | 7.30 |
| 1813 | Free cholesterol in small HDL | GCST90499411 | 7.30 |
| 1814 | SUSD2 levels | GCST90470787 | 7.29 |
| 1815 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176 | ECGU000176 | 7.29 |
| 1816 | GLOD4 levels | GCST90469359 | 7.28 |
| 1817 | IDP dMRI ProbtrackX L3 cgc l | GCST90004304 | 7.28 |
| 1818 | Free Cholesterol in LDL | GCST90498388 | 7.28 |
| 1819 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375 | ECGA000375 | 7.28 |
| 1820 | ANGPTL7 levels | GCST90468306 | 7.27 |
| 1821 | CPM levels | GCST90240598 | 7.26 |
| 1822 | Triglycerides | Blood biochemistry | UKBB00000861 | 7.26 |
| 1823 | CTSF/CTSV ratio | GCST90314313 | 7.26 |
| 1824 | S100P levels | GCST90470520 | 7.26 |
| 1825 | BA-exvivo rh volume BA3a | GCST90002851 | 7.26 |
| 1826 | CD99L2 levels | GCST90468657 | 7.25 |
| 1827 | Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivity | GCST90302759 | 7.25 |
| 1828 | Triglycerides to Total Lipids in IDL percentage | GCST90497682 | 7.24 |
| 1829 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502570 | 7.23 |
| 1830 | Omega-6 fatty acids to total fatty acids percentage | GCST90502545 | 7.22 |
| 1831 | Angina pectoris | Ischaemic heart diseases | UKBB00000031 | 7.22 |
| 1832 | HSD11B1 levels | GCST90469482 | 7.22 |
| 1833 | LDLR/PCSK9 ratio | GCST90315311 | 7.21 |
| 1834 | Concentration of VLDL particles (UKB data field 23428) | GCST90269525 | 7.21 |
| 1835 | Alcohol frequency weekly (standard GWA) | GCST90267266 | 7.21 |
| 1836 | Colon cancer | GCST90011811 | 7.20 |
| 1837 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28 | ECGA000028 | 7.19 |
| 1838 | F-healthy food liking (derived food-liking factor) | GCST90094779 | 7.19 |
| 1839 | CD58/IL10RB ratio | GCST90313850 | 7.19 |
| 1840 | Linoleic acid levels | GCST90502307 | 7.18 |
| 1841 | CDKN1A/TMSB10 ratio | GCST90313978 | 7.18 |
| 1842 | aparc-DKTatlas lh thickness paracentral | GCST90003555 | 7.18 |
| 1843 | FGA levels | GCST90469216 | 7.18 |
| 1844 | ADGRE5/GAS6 ratio | GCST90313179 | 7.18 |
| 1845 | IDP dMRI TBSS MO Posterior corona radiata R | GCST90003978 | 7.18 |
| 1846 | Red cell distribution width | GCST90002369 | 7.17 |
| 1847 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle L | GCST90004338 | 7.17 |
| 1848 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502388 | 7.17 |
| 1849 | FNDC1 levels | GCST90469256 | 7.17 |
| 1850 | CRKL/SERPINB1 ratio | GCST90314272 | 7.16 |
| 1851 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T109 | ECGA000109 | 7.16 |
| 1852 | Osteoporosis (PheCode 743.1) | GCST90476384 | 7.16 |
| 1853 | ALB levels | GCST90278616 | 7.15 |
| 1854 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498199 | 7.15 |
| 1855 | MIF/SUSD2 ratio | GCST90315452 | 7.15 |
| 1856 | SERPING1 levels | GCST90470600 | 7.14 |
| 1857 | Worry | GCST006478 | 7.14 |
| 1858 | NCK2/VASH1 ratio | GCST90315526 | 7.13 |
| 1859 | High light scatter reticulocyte percentage of red cells | GCST004612 | 7.13 |
| 1860 | Cholesteryl ester levels in medium LDL | GCST90092906 | 7.12 |
| 1861 | Other aneurysm (PheCode 442) | GCST90475992 | 7.12 |
| 1862 | T1 FreeSurfer DK rh supramarginal volume | GCST90385787 | 7.12 |
| 1863 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246 | ECGU000246 | 7.11 |
| 1864 | CD244/GP1BA ratio | GCST90313766 | 7.11 |
| 1865 | AXIN1/SRPK2 ratio | GCST90313417 | 7.11 |
| 1866 | IDP dMRI TBSS L2 Inferior cerebellar peduncle R | GCST90004133 | 7.10 |
| 1867 | ESM1 levels | GCST90469153 | 7.09 |
| 1868 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T339 | ECGA000339 | 7.09 |
| 1869 | NXPH3 levels | GCST90470112 | 7.09 |
| 1870 | SERPIND1 levels | GCST90470595 | 7.09 |
| 1871 | ICAM1 levels | GCST90469498 | 7.09 |
| 1872 | HAVCR2 levels | GCST90469432 | 7.09 |
| 1873 | ITPR1 levels | GCST90469655 | 7.07 |
| 1874 | NAGK levels | GCST90469995 | 7.06 |
| 1875 | Treatment or medication use - atorvastatin (UKB data field 20003_1141146234) | GCST90042376 | 7.06 |
| 1876 | B4GALT1/IFNGR1 ratio | GCST90313430 | 7.06 |
| 1877 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 7.05 |
| 1878 | Saturated fatty acid levels | GCST90092980 | 7.05 |
| 1879 | Ceramide_40:1_[M-H]1- levels | GCST90060198 | 7.04 |
| 1880 | PTP4A3 levels | GCST90470375 | 7.04 |
| 1881 | Platelet count | GCST004603 | 7.04 |
| 1882 | Hepatomegaly (PheCode 573.3) | GCST90476092 | 7.04 |
| 1883 | VCAN levels | GCST90471032 | 7.02 |
| 1884 | Neutrophil count | GCST90002352 | 7.01 |
| 1885 | IL6ST/MARCO ratio | GCST90315167 | 7.01 |
| 1886 | DCXR/GSTA1 ratio | GCST90314437 | 7.00 |
| 1887 | Phospholipids in VLDL (UKB data field 23412) | GCST90269509 | 6.99 |
| 1888 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497579 | 6.99 |
| 1889 | Monounsaturated fatty acid levels | GCST90092928 | 6.98 |
| 1890 | Triglycerides in medium VLDL (UKB data field 23508) | GCST90269605 | 6.98 |
| 1891 | Free cholesterol in small VLDL (UKB data field 23514) | GCST90269611 | 6.98 |
| 1892 | CPM/PCSK9 ratio | GCST90314216 | 6.98 |
| 1893 | FKBP5/ZBTB16 ratio | GCST90314850 | 6.97 |
| 1894 | NRCAM/PCDH17 ratio | GCST90315553 | 6.97 |
| 1895 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380 | ECGA000380 | 6.97 |
| 1896 | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels | GCST90199649 | 6.96 |
| 1897 | IDP dMRI TBSS L3 Superior cerebellar peduncle L | GCST90004184 | 6.96 |
| 1898 | DBNL/DNAJA2 ratio | GCST90314415 | 6.96 |
| 1899 | Monounsaturated fatty acid levels | GCST90502030 | 6.95 |
| 1900 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T348 | ECGA000348 | 6.95 |
| 1901 | PTGES2 levels | GCST90470369 | 6.94 |
| 1902 | Triacylglycerol_56:4_[M+NH4]1+ levels | GCST90060556 | 6.94 |
| 1903 | DTI autoptx L2 ptr r tract | GCST90385186 | 6.94 |
| 1904 | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | GCST90004344 | 6.94 |
| 1905 | Plasma N-acetyltaurine levels in chronic kidney disease | GCST90265600 | 6.93 |
| 1906 | Cholesteryl esters to total lipids ratio in medium LDL | GCST90092907 | 6.93 |
| 1907 | ATG4A/NSFL1C ratio | GCST90313368 | 6.93 |
| 1908 | T1 FreeSurfer DKT rh supramarginal volume | GCST90384377 | 6.92 |
| 1909 | RNF43 levels | GCST90422482 | 6.91 |
| 1910 | ALCAM levels | GCST90468279 | 6.90 |
| 1911 | Triglycerides to total lipids ratio in very large HDL | GCST90093015 | 6.90 |
| 1912 | CLEC11A levels | GCST90468764 | 6.89 |
| 1913 | ADM/CLMP ratio | GCST90313197 | 6.89 |
| 1914 | Concentration of small VLDL particles (UKB data field 23509) | GCST90269606 | 6.89 |
| 1915 | Free cholesterol to total lipids ratio in very small VLDL | GCST90093033 | 6.89 |
| 1916 | Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500539 | 6.89 |
| 1917 | MAD1L1 levels | GCST90469836 | 6.89 |
| 1918 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T399 | ECGU000399 | 6.88 |
| 1919 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500791 | 6.88 |
| 1920 | Total Phosphatidylethanolamine levels | GCST90025207 | 6.87 |
| 1921 | CD209/CLEC4G ratio | GCST90313750 | 6.87 |
| 1922 | Parental longevity (mother's attained age) | GCST006696 | 6.87 |
| 1923 | PLXNA4/SUSD1 ratio | GCST90315689 | 6.87 |
| 1924 | Cholesteryl Esters in Small LDL | GCST90499578 | 6.87 |
| 1925 | N6,N6-dimethyllysine levels in chronic kidney disease | GCST90257529 | 6.86 |
| 1926 | CPA2/ITGB7 ratio | GCST90314207 | 6.86 |
| 1927 | Offspring birth weight | GCST005314 | 6.86 |
| 1928 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499530 | 6.86 |
| 1929 | triglyceride (maximum, inv-norm transformed) | GCST90476431 | 6.86 |
| 1930 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89 | ECGU000089 | 6.86 |
| 1931 | SNX5 levels | GCST90470702 | 6.86 |
| 1932 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502555 | 6.85 |
| 1933 | CD40LG/TRAF2 ratio | GCST90313828 | 6.85 |
| 1934 | Concentration of large LDL particles (UKB data field 23530) | GCST90269627 | 6.85 |
| 1935 | Total lipids in small VLDL | GCST90499849 | 6.85 |
| 1936 | Mean corpuscular hemoglobin concentration | GCST90002328 | 6.84 |
| 1937 | MET/PTPRF ratio | GCST90315435 | 6.84 |
| 1938 | In your lifetime, have you smoked a total of at least 100 cigarettes? | GCST90476387 | 6.84 |
| 1939 | Alkenylphosphatidylcholine (P-36:3) levels | GCST90024954 | 6.84 |
| 1940 | Total fatty acid levels | GCST90502711 | 6.84 |
| 1941 | Sphingomyelin_40:2_[M+H]1+ levels | GCST90060352 | 6.83 |
| 1942 | DECR1/STX8 ratio | GCST90314452 | 6.83 |
| 1943 | PCSK9 levels | GCST90428110 | 6.83 |
| 1944 | aseg global volume CC-Central | GCST90002609 | 6.83 |
| 1945 | Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | GCST90475673 | 6.83 |
| 1946 | Cholesteryl Esters in VLDL | GCST90500205 | 6.82 |
| 1947 | 4-hydroxyglutamate levels | GCST90199890 | 6.82 |
| 1948 | Ever felt worried, tense, or anxious for most of a month or longer | Anxiety | UKBB00000215 | 6.82 |
| 1949 | Total concentration of lipoprotein particles (UKB data field 23427) | GCST90269524 | 6.80 |
| 1950 | MCFD2/VSIR ratio | GCST90315411 | 6.80 |
| 1951 | CCL21 levels | GCST90468573 | 6.80 |
| 1952 | Feeling fed-up | GCST006947 | 6.79 |
| 1953 | Cholesteryl esters in small LDL (UKB data field 23548) | GCST90269645 | 6.79 |
| 1954 | Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | GCST90500569 | 6.79 |
| 1955 | Alkaline phosphatase (UKB data field 30610) | GCST90468060 | 6.79 |
| 1956 | Triacylglycerol_56:6_[M+NH4]1+ levels | GCST90060553 | 6.79 |
| 1957 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 6.79 |
| 1958 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498058 | 6.79 |
| 1959 | Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500542 | 6.78 |
| 1960 | IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R | GCST90004511 | 6.77 |
| 1961 | Familial combined hyperlipidemia defined by Consensus criteria | GCST90104006 | 6.77 |
| 1962 | SEZ6L2 levels | GCST90470606 | 6.77 |
| 1963 | P4HB levels | GCST90470140 | 6.76 |
| 1964 | IGF1R levels | GCST90469524 | 6.76 |
| 1965 | GABARAPL1 levels | GCST90469287 | 6.75 |
| 1966 | DTI TBSS L2 Superior fronto-occipital fasciculus R | GCST90384518 | 6.75 |
| 1967 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358 | ECGA000358 | 6.74 |
| 1968 | aparc-DKTatlas rh area fusiform | GCST90003270 | 6.74 |
| 1969 | Lifespan | GCST90551885 | 6.73 |
| 1970 | Polyunsaturated fatty acid levels | GCST90502134 | 6.73 |
| 1971 | C4 levels | GCST90281042 | 6.73 |
| 1972 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170 | ECGA000170 | 6.73 |
| 1973 | CD200R1/CLEC4G ratio | GCST90313748 | 6.73 |
| 1974 | T1 FreeSurfer DK lh superiortemporal thickness | GCST90385651 | 6.72 |
| 1975 | Free cholesterol in very small VLDL (UKB data field 23521) | GCST90269618 | 6.72 |
| 1976 | SFRP2 levels | GCST90242727 | 6.72 |
| 1977 | APOM/ERBB3 ratio | GCST90313314 | 6.72 |
| 1978 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498007 | 6.71 |
| 1979 | Triglycerides in very large HDL | GCST90500482 | 6.71 |
| 1980 | ICD10 N86: Erosion and ectropion of cervix uteri | GCST90454217 | 6.71 |
| 1981 | IDP dMRI TBSS L3 Inferior cerebellar peduncle L | GCST90004182 | 6.71 |
| 1982 | BTC levels | GCST90468476 | 6.70 |
| 1983 | BSG levels | GCST90468472 | 6.70 |
| 1984 | Total lipids in VLDL (UKB data field 23424) | GCST90269521 | 6.69 |
| 1985 | Phospholipids in very large VLDL | GCST90500644 | 6.69 |
| 1986 | IGBP1 levels | GCST90469521 | 6.69 |
| 1987 | Other localized connective tissue disorders | FING00001066 | 6.68 |
| 1988 | Triacylglycerol_52:4_[M+NH4]1+ levels | GCST90060508 | 6.68 |
| 1989 | Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels | GCST90060446 | 6.68 |
| 1990 | LPL levels | GCST90469788 | 6.68 |
| 1991 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 6.67 |
| 1992 | CTSZ/NAAA ratio | GCST90314320 | 6.66 |
| 1993 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12 | ECGA000012 | 6.65 |
| 1994 | Triglyceride levels in VLDL | GCST90093003 | 6.65 |
| 1995 | Other diseases of blood and blood-forming organs | FING00000998 | 6.64 |
| 1996 | CALCOCO1/INPPL1 ratio | GCST90313603 | 6.64 |
| 1997 | Total fatty acid levels | GCST90502212 | 6.63 |
| 1998 | Treatment speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000832 | 6.63 |
| 1999 | Sleep apnea (MTAG) (adjusted for BMI) | GCST90267364 | 6.62 |
| 2000 | DTI TBSS MD Anterior corona radiata R | GCST90384594 | 6.62 |